0 results found with selected filters. Please refine the filters. Redirecting to initial search..
Table "column sort" updates the order of the bars in the chart.
downloaded on: 2025/12/08 14:02:20
| Strain |
Phenotype |
Conditions |
Study |
Experiment Name |
Sex |
Age |
# of Animals |
Value |
Units |
SEM |
SD |
Method |
Method Duration |
Post Insult Type |
Post Insult Time Value |
Method Notes |
Clinical Measurement Notes |
Record ID |
Study ID |
| SD |
brain uptake index of quinidine |
tritiated quinidine (10 uCi) (for 0 hours) and quinidine (10 mmol/l) (for 0 hours) |
Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. |
brain molecular composition trait |
male |
35.0 days-49.0 days |
3 |
18.2 |
% |
1.2 |
2.08 |
liquid scintillation counting |
0.0 |
carotid injection |
15 |
sec post excision |
quinidine uptake index |
106151 |
3028 |
| SD |
brain uptake index of quinidine |
tritiated quinidine (10 uCi) (for 0 hours) and vehicle control condition (for 0 hours) |
Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. |
brain molecular composition trait |
male |
35.0 days-49.0 days |
3 |
2.12 |
% |
0.12 |
0.21 |
liquid scintillation counting |
0.0 |
carotid injection |
15 |
sec post excision |
quinidine uptake index |
106150 |
3028 |
| SD |
brain uptake index of quinidine |
tritiated quinidine (10 uCi) (for 0 hours) and verapamil (3 mmol/l) (for 0 hours) |
Fujii S, et al., Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4650-8. doi: 10.1167/iovs.13-13819. |
brain molecular composition trait |
male |
35.0 days-49.0 days |
3 |
13.2 |
% |
3.2 |
5.54 |
liquid scintillation counting |
0.0 |
carotid injection |
15 |
sec post excision |
quinidine uptake index |
106152 |
3028 |
|